Washington Proposed Medical Cannabis Certification Plan
The state liquor and cannabis board is seeking public input on a new certification process for medical marijuana industry members.
Updated on Oct. 12, 2026 in Organic Food
Live Poll
Should the state implement an additional medical certification program for legal marijuana businesses?
The Washington Liquor and Cannabis Board has opened a public comment period regarding a proposed medical marijuana certification program. This initiative aims to improve regulatory clarity for growers, processors, and retailers across the state.
Why it matters
The board hopes to better verify industry participation and information to assist with federal registration, banking, and insurance requirements. This shift could impact how medical cannabis operations in Washington navigate legal and financial complexities.
Official filings show Washington is one of 9 states currently using a single general marijuana license for all industry entities, costing $1,781. The extent to which this new certification program will alter existing licensing or create new requirements is currently under investigation.
The players
Washington Liquor and Cannabis Board
The state regulatory agency responsible for managing the licensure and oversight of marijuana industry entities in Washington.
The details
The board is currently soliciting feedback from citizens, growers, processors, and retailers to help shape the certification framework. By separating medical-focused activities from general licensing, the state aims to align better with federal classifications, which treat unlicensed cannabis as a Schedule 1 drug and medical cannabis as a Schedule 3 drug. This distinction is intended to provide businesses with the documentation needed for insurance, banking, and federal regulatory registration.
Timeline
December 4, 2026: End of public comment period for certification program.
Health Landscape
This proposal reflects a growing effort by states to bridge the divide between state-sanctioned medical cannabis programs and the federal Controlled Substances Act's Schedule 1 and Schedule 3 classifications. It highlights the ongoing challenges of banking and insurance access for industry entities.
If you use or rely on medical cannabis, this regulatory update may eventually influence the availability and stability of your medical supply. Any concerns regarding how these policy shifts affect your access to medical-grade products are worth discussing with your doctor.
The takeaway
The board is seeking public input to refine how medical cannabis is tracked and regulated within Washington state. Residents and industry members should monitor the outcome of this comment period to understand how certification changes may affect local market standards.
Further reading
Learn more about the latest regulatory updates in our Organic Food section.
More information
Submit your comments or review the proposal through the WA Liquor Control comment submission portal.
Source note: This article includes information reported by News Radio 610 KONA.
Live Poll
Should the state implement an additional medical certification program for legal marijuana businesses?
